These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2089604)

  • 1. [Alternatives to classical immunotherapy and future possibilities].
    Casillas Miranda R; Boudet RV; Vanella LM
    Rev Alerg Mex (1987); 1990; 37(4):133-5. PubMed ID: 2089604
    [No Abstract]   [Full Text] [Related]  

  • 2. [The mechanisms of allergen-specific immunotherapy more clear].
    Rak S
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1935-7. PubMed ID: 18681375
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alternatives to classic immunotherapy and future possibilities].
    Casillas Miranda R; Boudet RV; Vanella LM
    Rev Alerg Mex (1987); 1990; 37(3):101-4. PubMed ID: 2087619
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy with allergens.
    Creticos PS; Norman PS
    JAMA; 1987 Nov; 258(20):2874-80. PubMed ID: 3312669
    [No Abstract]   [Full Text] [Related]  

  • 5. [Status report on allergen immunotherapy (hyposensitisation). Prepared by the WHO/IUIS Immunotherapy Subcommittee 1988].
    Malling HJ
    Ugeskr Laeger; 1989 Nov; 151(48):3249-52. PubMed ID: 2595857
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergen Immunotherapy: Vaccine Modification.
    Creticos PS
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):103-24. PubMed ID: 26617230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on vaccines for specific immunotherapy.
    Jensen-Jarolim E; Wallmann J; Szalai K; Epstein M; Singh P; Hartl A; Thalhamer J; Pali-Scholl I
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():97-8. PubMed ID: 19221632
    [No Abstract]   [Full Text] [Related]  

  • 8. Local reactions from subcutaneous allergen immunotherapy.
    Coop CA
    Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific immunotherapy in allergies--evaluation of current status].
    Jarisch R; Hemmer W
    Wien Med Wochenschr; 1996; 146(15):422-5. PubMed ID: 9012204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of immunotherapy with individual allergens: Immunotherapy with fungi.
    Pineda F
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():36-38. PubMed ID: 29129403
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic mechanisms of allergen-specific immunotherapy.
    Akdis CA; Blaser K
    Adv Exp Med Biol; 2001; 495():247-59. PubMed ID: 11774574
    [No Abstract]   [Full Text] [Related]  

  • 12. Sublingual immunotherapy.
    Heinzerling L; Worm M; Bergmann KC; Zuberbier T
    J Dtsch Dermatol Ges; 2006 May; 4(5):428-33; quiz 434-5. PubMed ID: 16686612
    [No Abstract]   [Full Text] [Related]  

  • 13. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
    Wilcock LK; Francis JN; Durham SR
    Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantages and disadvantages of accelerated immunotherapy schedules.
    Cox L
    J Allergy Clin Immunol; 2008 Aug; 122(2):432-4. PubMed ID: 18619664
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of allergen immunotherapy (hyposensitization): memorandum from a WHO/IUIS meeting.
    Bull World Health Organ; 1989; 67(3):263-72. PubMed ID: 2670296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of allergen immunotherapy (hyposensitization). Report of a WHO/IUIS working Group.
    Allerg Immunol (Leipz); 1989; 35(4):235-47. PubMed ID: 2696375
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting Mast Cells with Biologics.
    Lyons JJ; Metcalfe DD
    Immunol Allergy Clin North Am; 2020 Nov; 40(4):667-685. PubMed ID: 33012327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyposensitization].
    Przybilla B; Ring J
    Internist (Berl); 1991 Oct; 32(10):606-11. PubMed ID: 1761393
    [No Abstract]   [Full Text] [Related]  

  • 19. [Specific immunotherapy: indications and contraindications].
    Reinhardt MC
    Rev Med Suisse Romande; 1994 Mar; 114(3):233-43. PubMed ID: 8171233
    [No Abstract]   [Full Text] [Related]  

  • 20. Current status of allergen immunotherapy. Shortened version of a World Health Organisation/International Union of Immunological Societies Working Group Report.
    Lancet; 1989 Feb; 1(8632):259-61. PubMed ID: 2563421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.